SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 115 filers reported holding SANGAMO THERAPEUTICS INC in Q4 2013. The put-call ratio across all filers is 0.10 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $2,721,000 | -49.1% | 482,500 | 0.0% | 0.16% | -45.5% |
| Q2 2015 | $5,351,000 | -29.3% | 482,500 | 0.0% | 0.29% | -49.0% |
| Q1 2015 | $7,566,000 | +3.1% | 482,500 | 0.0% | 0.57% | -29.0% |
| Q4 2014 | $7,339,000 | +41.0% | 482,500 | 0.0% | 0.80% | +10.2% |
| Q3 2014 | $5,204,000 | -29.4% | 482,500 | 0.0% | 0.73% | -27.4% |
| Q2 2014 | $7,368,000 | -11.9% | 482,500 | +4.3% | 1.00% | -22.8% |
| Q1 2014 | $8,362,000 | +177.1% | 462,500 | +112.8% | 1.30% | +39.6% |
| Q4 2013 | $3,018,000 | – | 217,300 | – | 0.93% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FIC CAPITAL INC | 875,284 | $2,670,000 | 1.34% |
| NEXTHERA CAPITAL LP | 503,000 | $1,534,000 | 0.90% |
| Opaleye Management Inc. | 400,000 | $1,220,000 | 0.72% |
| WASATCH ADVISORS LP | 7,256,260 | $22,132,000 | 0.33% |
| Cormorant Asset Management, LP | 650,000 | $1,983,000 | 0.27% |
| Sicart Associates LLC | 101,950 | $311,000 | 0.22% |
| Baker Brothers Advisors | 4,055,876 | $12,370,000 | 0.12% |
| Leisure Capital Management | 43,008 | $131,000 | 0.12% |
| Piermont Capital Management Inc. | 165,569 | $505,000 | 0.12% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 837,963 | $2,556,000 | 0.10% |